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Introduction: 
             Neurodegenerative diseases are characterized by a number of brain disorders with 
different symptoms such as dementia, disordered movements etc. and often it occurs in later 
stages of life. Aggregation and deposition of misfolded proteins in brain cells is the main 
cause of these disorders (Taylor et al., 2002). The proteins involved in neurodegenerative 
disorders are characterized by the presence of intracellular or extracellular protein deposits in 
the form of proteinaceous fibrils or amyloids (Caughey and Lansbury, 2003). These 
deposits have a characteristic of cross-β structure and are defined by their distinct 
morphological properties (Sunde and Blake, 1997; Sipe and Cohen, 2000).  
           Human synucleins are natively unfolded proteins and are characterized by low overall 
hydrophobicity and large net charge. The hydrodynamic radii of these proteins are closer to 
random coils than for globular proteins. However, these proteins may be significantly folded 
in their normal cellular milieu after binding to specific ligands (Uversky, 2002, Davidson et 
al., 1998; Eliezer et al., 2001). The human synucleins family (α, β and γ) are comprised of 
small proteins (~14k Da) and expressed at high levels in the neurons. These proteins are heat 
stable and relatively soluble (George et al., 1995; Jakes et al., 1994) and characterized by 
absence of cysteines and tryptophans. 
α-synuclein (SNCA/ α-syn):  
              The α-gene has been specifically implicated in the Parkinson’s (PD) and 
Alzheimer’s (Maroteaux et al., 1988; Jakes et al., 1994) and has been found in the Lewy 
body inclusions in neurons (Spillantini et al., 1998). In vitro studies have revealed that α syn 
is more fibrillogenic than β and γ syn (Biere et al., 2000). Furthermore, α and β syn interact 
with each other and β syn inhibits α syn aggregation due to its chaperonic activity (Uversky 
et al., 2002; Park and Lansbury, 2003). α syn protein might also have a role in synaptic 
development, function and plasticity (Clayton and George, 1998; Cabin et al., 2002). α syn 
binds to lipid membranes (Davidson et al., 1998) and also interacts with other proteins such 
as synphilin (Kawamata et al., 2001) and tubulin (Payton et al., 2001).   
 β-synuclein (SNCB/ β-syn):  
             Human β syn is a 134 amino acid protein. β-syn is deficient in the non-
amyloidogenic component (NAC) domain that is believed to be responsible for the 
aggregating properties of α-syn (Jensen et al., 1995). Therefore β-syn is considered to be a 
non-amyloidogenic homolog of α-syn (El-Agnaf and Irvine, 2000). It is postulated that β 
syn could act as a physiological inhibitor of α syn aggregation (Hashimoto et al., 2001).   
 
γ- synuclein (SNCG/ γ- syn):  
                γ syn is believed to be involved in neurodegenerative diseases and in non-neural 
disease like breast cancer. γ syn is principally expressed in the brain, particularly in the 
substantia nigra.  γ syn is primarily found in the peripheral nervous system (in primary 
sensory neurons, sympathetic neurons, motor neurons and retina) (George, 1995). It is also 
detected in the brain, ovarian tumors, and in the olfactory epithelium. γ syn is the least 
conserved of the synuclein proteins in comparison with the α syn and β syn (Lavedan, 1998).  
                Human synuclein proteins share high sequence similarities amongst themselves and 
are intrinsically disordered proteins (IDPs) in nature, having partially folded structure. The 
function of the human synucleins and their involvement in various synucleiopathies are not 
clear till date. While most of the studies are available for α-syn, few studies have been carried 
out on β-syn and γ-syn. In the present work, we have studied pH, concentration and 
temperature dependent conformational changes and aggregation behavior of the three human 
synucleins. We have also carried out studies on the effect of structure stabilizing cosolvent 
trehalose, known to stabilize the native state of the proteins, on the structure and aggregation 
of synucleins. In addition, the effect of Ca(II) and dopamine (DA), known to play a 
significant role in the signaling process, on the stability, aggregation, binding and 
cytotoxicity effect of synucleins has also been investigated. Various morphological changes 
in amyloids fibers in the above conditions have also been analyzed and the results correlated 
with the cytotoxicity effect on human neuroblastoma cells (SHSY5Y) of the species formed 
under different conditions.        
 
Methodology: 
Protein expression and purification 
            Expression and purification of the human recombinant α-Syn, β-syn, γ-Syn and 
familial mutants (A30P, E46K and A53T), H50A of human α-Syn from E. coli was carried 
out according to Volles and Lansbury Jr., 2007 and the identity confirmed using Matrix-
assisted laser desorption/ionisation-time of flight mass spectrometry (MALDI-TOF MS) 
while the mutations were identified using DNA sequencing to know the exact position of the 
mutation.  
Gel filtration chromatography 
            Gel filtration chromatography of the human recombinant α-Syn, β-syn and γ-Syn 
from E. coli was carried out using an AKTA Basic 10 FPLC instrument and a Hi Prep 16/60 
Sephracryl S-200 HR column from GE Healthcare at 25ºC.  
Spectroscopic measurements of human synucleins 
           Intrinsic absorbance of tyrosine and temperature-induced conformational changes of 
human synucleins was recorded using UV-visible spectrometric measurements on a Cary 
Varian UV-visible spectrometer attached with a peltier temperature controller. Fluorescence 
emission spectra in different conditions were recorded on a Cary Varian Eclipse fluorimeter 
attached with a peltier temperature attachment. Tyrosine was used as a probe for fluorescence 
studies. Acrylamide quenching studies of intrinsic tyrosine fluorescence were carried out by 
adding different concentrations of the quencher into a cuvette containing the protein solution 
and the additives at a particular concentration and data were analyzed using the Stern-Volmer 
equation. 8-anilino-1-naphthalene-sulphonic acid (ANS) binding spectra were recorded from 
400-600 nm with excitation at 350 nm at 25˚C. The final ratio of ANS to protein 
concentration was equal to 5. Thioflavin T (ThT) fluorescence assay for fibril formation were 
carried out using Thioflavin T assay at a protein concentration of 1.0 mg/ml at 37°C, pH 7.5 
and shaking at 200 rpm for several days. ThT fluorescence was excited at 445 nm and the 
emission intensity was recorded at 480 nm.  
Circular Dichroism (CD) measurements: 
             Far-UV CD (190-260nm) and near UV-CD (250-350nm) spectra were recorded using 
Jasco J-815 model spectropolarimeter equipped with a peltier based temperature controller.  
Thermal stability of the human synucleins using Differential Scanning Calorimetry 
(DSC): 
            DSC experiments were carried out using a VP-DSC instrument from Micorcal LLC., 
Northampton, USA. Protein samples (70 μM) are prepared in 10 mM phosphate buffer at pH 
7.4 and dialyzed overnight against respective buffer.  
Isothermal Titration Calorimetry (ITC) to calculate the binding affinity of Ca(II) with 
human synucleins: 
            The binding energetics of human synucleins and familial mutants A30P, E46K and 
A53T of α-syn with Ca(II) were studied using a isothermal titration calorimeter (VP-ITC) 
from Microcal LLC., Northampton, MA.  Integrated heat data were fitted using the MicroCal 
Origin software.  
Morphological analysis of aggregates using transmission electron microscopy (TEM): 
           Morphological states of aggregates have been observed using JEM-2100, JEOL 
Transmission electron microscope (TEM) by negative staining method. 
 
 
MTT cytotoxicity assay using human neuroblastoma cells SHSY5Y: 
             Cell toxicity assay for various protein species formed during the aggregation pathway 
viz. oligomers, multimers, protofibrils and fibrils of human synucleins in presence of Ca(II), 
dopamine and trehalose were carried out using human neuroblastoma cells SH-SY5Y in a 
time dependent manner. Cell viability was determined using an MTT (3-[4,5-dimethylthiazol-
2-yl]-2,5-diphenyltetrazolium bromide) toxicity assay at 570 nm using Spectra Max 384 plus 
microplate reader from Molecular devices. 
Results and Discussion: 
              Results and discussion section has been divided into the following chapters:  
Chapter 1: Characterization of human synucleins (α, β and γ) on the basis of their 
conformational and fibrillation properties 
              Followed by expression of the recombinant human synucleins (α, β and γ), purity 
was confirmed by matrix assisted laser desorption ionization-time of flight (MALDI-TOF) 
mass spectrometry and SDS-PAGE. Native gel electrophoresis data indicate that β-syn is 
more structured than α-Syn while γ-syn is less structured than both α- and β-syn based on 
their mobility. Gel filtration chromatography of human synucleins denatured by 8M urea or 
6M GdmCl resulted in the denatured protein eluting out first in the elution volume as 
compared to the native human synucleins suggesting increased hydrodynamic radius of the 
denatured protein compared with the native protein. Human synucleins have been structurally 
characterized using UV absorption and fluorescence spectrophotometry and CD 
spectroscopy. Differential scanning calorimetry (DSC) was employed to monitor thermal 
transitions and their reversibility. While β- and γ-syn were observed to be reversible after 
heating up to 100 ºC, α-syn was irreversible and aggregated at high temperatures. Extensive 
studies on conformational changes as well as aggregation propensity of human synucleins as 
a function of pH, temperature, concentration of protein and denaturants have been carried out. 
Low pH, high temperatures and high protein concentration promoted fibril formation. ANS 
binding studies at different pH values showed pH-induced transformation from the natively 
unfolded state to a partially folded compact conformation in α- and γ-syn. α syn was also 
observed to have the highest propensity for fibrillation. Morphological characterization of the 
aggregates was done by using TEM. On the basis of sequence analysis using ClustalW, 
human synucleins shared more than 70% sequence homology. Out of these three proteins, α- 
and β-syn share high homology with each other in comparison to γ syn. C-terminal of γ syn is 
less conserved due to which its properties are slightly different from α- and β-syn. However, 
β syn does not form amyloids under physiological conditions due to the absence of amyloid 
forming residues in its sequence. Thus, by using bioinformatics sequence analysis tools 
together with spectroscopy and other biophysical techniques, we have been able look into the 
sequence-structure relationship in human synucleins.  
Chapter 2: Effect of Trehalose, a naturally occurring osmolytes on the conformational 
and fibrillation properties of human synucleins 
              Human synucleins are disordered proteins at physiological pH and it is expected that 
structure can be induced by using structure stabilizing cosolvent additives or osmolytes. 
Protein stabilization by cosolvent additives has been extensively studied in our laboratory 
(Kaushik and Bhat, 1999, 2003). Most of the osmolyte driven stabilization studies have 
been carried out for globular proteins. We used trehalose-a strong structure stabilizing agent, 
produced in organisms under stress conditions, in order to study its effect on the 
conformational and aggregation properties of human synucleins. Based on intrinsic tyrosine 
fluorescence, ANS binding, acrylamide quenching, far-UV and Near-UV CD data, it was 
observed that trehalose induces conformational changes from natively disordered state to 
partially folded state of human synucleins. Contrast to expectations, trehalose enhanced the 
fibril forming propensity of human synucleins and in familial mutants (A30P, E46K & A53T) 
of human α syn in a concentration dependent manner as monitored by ThT assay. Fibril 
morphology in the presence of trehalose was characterized using TEM. Aggregation species 
(oligomers, protofibrils and mature fibril) formed in presence of trehalose was toxic to human 
neuroblastoma cells. It is interesting to note that in case of globular proteins, trehalose is 
known to inhibit aggregation (Liu et al., 2005; Vilasi et al., 2008; Kaushik and Bhat, 1999, 
2003) while in the case of human synucleins trehalose promoted fibrillation. Trehalose is 
known to be preferentially excluded from the proteins surface and favors the compaction of 
the protein molecules in case of globular protein (Xie and Timasheff, 1997). Therefore, 
presence of trehalose would favor more compact forms of human synucleins than the 
intrinsically disordered state and these folded intermediate states of synucleins may form a 
nucleus for further association to lead to fibril formation. The formation of a compact, 
partially folded state of human synucleins, in presence of trehalose would, thus, result in the 
shifting of the equilibrium from intrinsically disordered state-intermediate partially folded 
state- ordered fibrillar state.    
Chapter 3: Calcium and dopamine-induced conformational and morphological changes 
in human synucleins and their effect on the propensity of fibrillation 
             Ca(II) is known to play an important role in the propagation of the action potentials 
in neurons and release of neurotransmitters (Berridge, 1998a). Ca(II) interacts with C-
terminus of human α-syn and is involved in the signaling process (Nielsen et al., 2001). Also 
oxidative stress is linked to an increase in the Ca(II) influx and intracellular Ca(II)
 
levels in 
the brain cells that disrupt normal cellular processes (Cuschieri et al., 2005). It has recently 
been hypothesized that high cytoplasmic Ca(II), elevated cytosolic DA and α-syn expression 
induced selective death of dopaminergic neurons from substantia nigra (SN) region of mid 
brain (Mosharov et al., 2009). Considering the importance of Ca(II), we studied its effect on 
the conformational changes, binding, aggregation propensity along with morphological 
changes in the amyloids fibrils of human synucleins. Various fluorescence techniques like 
intrinsic tyrosine fluorescence, ANS binding was used to investigate the interaction of Ca(II) 
which confirmed that Ca(II) binds to human α and β syn. Far-UV CD showed little changes 
in the secondary structures. ITC measurements showed that Ca(II) binds to the α, β syn and 
the familial mutants of α-syn. These binding interactions are weak and endothermic in nature. 
While the binding constant for the interaction of Ca(II) with α and β syn were 2.2×10-3 M-1, 
0.9×10-3 M-1 respectively. There was no appreciable binding between γ- syn and Ca(II). 
Fibrillation propensity of human α, γ syn and the familial mutants of α syn except β syn are 
enhanced in the presence of Ca(II).  
         We also studied the effect of dopamine (DA) alone and with Ca(II) on the fibrillation 
kinetics of human α syn. DA alone inhibits the propensity of fibrillation and induces the 
formation of oligomers. However, the presence of DA with Ca(II) shifts the fibril formation 
equilibrium from oligomers to protofibril state which is more toxic in nature. Cytotoxicity 
was determined at different time periods of incubation of the proteins on the aggregation 
pathway in the presence of Ca(II), DA and DA with Ca(II) using human neuroblastoma cells 
(SHSY5Y). It has been observed that Ca(II) and DA-induced aggregation is more toxic to the 
cells.  
           In the neuronal cytoplasm Ca(II), DA and human α syn are present together. The 
homeostasis amongst these is very critical to the survival of the dopaminergic neurons in the 
substantia nigra of the mid brain. As Ca(II) is a positively charged molecule and interacts 
with the negatively charged C-terminal of the human α syn. The binding of Ca(II) leads to 
subtle conformational changes in the human α syn resulting in toxic fibrillar species.  
             In summary, the results obtained in the present study are useful to understand the 
sequence and structure relationship of the three human synucleins. Trehalose induced fibril 
formation in human synucleins suggested that the mechanism of action of structure 
stabilizing osmolytes like trehalose is different for intrinsically disordered proteins compared 
with well folded globular proteins. Human α syn Ca(II) and DA homeostasis is very critical 
for survival of neurons in the midbrain and interference with any of these three factors may 
be very useful in survival of neurons. These studies altogether may be helpful in the design of 
strategies to treat this old age motor dysfunction disease. The studies further show that even 
though Ca(II) and DA bind weakly to α-syn, they can regulate critically the nature of 
aggregate formation tendency of the protein in terms of forming fibrils, protofibrils or 
oligomers which could play a role in the onset of Parkinson’s disease.  
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